Vaxcyte (PCVX)

• Market cap: $8.23B
• 1 day: 2.05%
• 5 days: 4.87%
• 1 month: 20.62%
• 3 months: 17.89%
• 6 months: 80.65%
• Year to date: 23.37%
• 1 year: -31.24%
• 5 years: 122%
• 10 years: 119.2%
• Sector: Healthcare
• Industry: Biotechnology

About: Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Employees: 414